Follow the money. At least, that’s what our columnist Braden Maccke, author of Market Movers: Else Nutrition, would say following Else Nutrition’s (TSXV: BABY) news this morning related to the US launch of trial samples of its nutrition products for toddlers. The launch is to consist of trial-sized pouches for the US market.
The company announced this morning that it will effectively be launching within the United States market, a major move for the firm whom previously only sold products in bulk to clients in Israel. Following “successful production,” the company will be making the trial products available for order on its online e-commerce platform.
Product trials will be available to consumers essentially for free, with consumers only required to cover the cost of shipping. The sampling campaign is said to precede the full launch of Else’s plant-based baby food products within the United States, which is expected to see pre-orders begin this July.
Further details on the expected launch were not provided.
Else Nutrition last traded at $2.14 on the TSX Venture.
Information for this briefing was found via Sedar and Else Nutrition. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.